AI assistant
Sending…
aTYR PHARMA INC — Director's Dealing 2021
Nov 15, 2021
34337_dirs_2021-11-15_34ff0d4e-ab6f-450c-aeb4-f4be177b1b45.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2021-11-15
Reporting Person: Shukla Sanjay (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Common Stock | P | 2500 | $8.575 | Acquired | 20798 | Direct |
More from aTYR PHARMA INC
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 11
Regulatory Filings
2026
Mar 26
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9